Patents Assigned to Imperial Innovations Limited
  • Patent number: 9995774
    Abstract: Determining a property of an electrical signal at a node instant at the current instant (INSTC); determining a previous function indicative of a property of the signal at the node at a previous instant; determining an error function in a previous frequency estimation at the node at a previous instant; determining a first current function indicative of the property of the signal at the node at INSTC in accordance with the determined property, the previous function, and the error function; receiving, from another node, a second current function indicative of a property of an electrical signal at the at least one other node at INSTC; combining the first current function and the second current function to produce a current combined function (CCF) indicative of a property of the signal at the node at INSTC; and estimating a current frequency of the signal at the node in accordance with the CCF.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: June 12, 2018
    Assignee: IMPERIAL INNOVATIONS LIMITED
    Inventors: Danilo Mandic, Yili Xia, Dahir Dini
  • Patent number: 9994675
    Abstract: The present invention provides a novel catalyst of formula (I): wherein M is selected from Zn(H), Co(II), Mn(II), Mg(II), Fe(II), Cr(III)-X or Fe(III)-X, and the use thereof in polymerizing carbon dioxide and an epoxide.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: June 12, 2018
    Assignee: Imperial Innovations Limited
    Inventors: Charlotte K. Williams, Michael Kember, Paul Knight
  • Publication number: 20180143145
    Abstract: A sensor comprises a first resonator operable at microwave and/or millimetre wave frequencies and having a first value of quality factor which is equal to or greater than moo at a frequency in a range 1 to 100 GHz and a second resonator having a second value of quality factor which is less than the first value of quality factor and which is positioned and orientated with respect to the first resonator so as to be inductively coupled to the first resonator, the second resonator comprising first and second electrically-conductive regions separated by a gap which provides a sensing region.
    Type: Application
    Filed: November 23, 2016
    Publication date: May 24, 2018
    Applicant: Imperial Innovations Limited
    Inventors: Norbert Klein, Clare Watts, Stephen Hanham
  • Patent number: 9950355
    Abstract: Method of forming a component of complex shape from an Al-alloy sheet or a Mg-alloy sheet. The method includes the steps of: a) heating the sheet to a temperature below the solution heat treatment (SHT) temperature for the alloy; b) forming the heated sheet between heated dies into or towards the complex shape; c) heating the sheet to at least its SHT temperature and substantially maintaining that temperature until SHT has been completed; and d) quenching the solution heat treated sheet between cold dies and at the same time completing the forming into the complex shape or maintaining that shape.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: April 24, 2018
    Assignee: Imperial Innovations Limited
    Inventors: Jianguo Lin, Daniel Balint, Lilang Wang, Trevor Anthony Dean, Alistair David Foster
  • Patent number: 9954243
    Abstract: A fuel cell comprising at least two stacked fuel cell boards (22) which each comprise a membrane of substantially gas impervious electrolyte material and at least two electrode pairs wherein the anode and cathode of each said electrode pair are arranged on respective faces of said membrane. An electrode of each pair of electrodes is connected to an electrode of an adjacent pair of electrodes by a through-membrane connection (13) or by an external connection on a Printed Circuit Board, comprising an electrically conductive region of said electrolyte material. A method for forming the through-membrane electrical connections in the electrolyte membrane is also disclosed.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: April 24, 2018
    Assignees: Imperial Innovations Limited, UCL Business PLC
    Inventors: Daniel John Leslie Brett, Anthony Robert John Kucernak
  • Patent number: 9943840
    Abstract: This invention relates to a process for the preparation of surface-functionalised metal oxide, metal sulphide, metal selenide or metal telluride nanoparticles, a process for the preparation of a composite material comprising such nanoparticles, nanoparticles and a composite material produced thereby, the use of such nanoparticles in catalysis and a catalyst comprising such nanoparticles.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: April 17, 2018
    Assignee: IMPERIAL INNOVATIONS LIMITED
    Inventors: Milo Shaffer, Charlotte Williams, Katherine Orchard, Neil John Brown, Jonathan Weiner
  • Patent number: 9944687
    Abstract: Peptide containing sequence from both the GLP-1 peptide and glucagon peptide, compositions comprising said peptides and methods of using said peptides for the treatment and prevention of metabolic disorders, for example disorders of energy metabolism such as obesity or diabetes, are provided.
    Type: Grant
    Filed: July 4, 2011
    Date of Patent: April 17, 2018
    Assignee: Imperial Innovations Limited
    Inventor: Stephen Robert Bloom
  • Patent number: 9932344
    Abstract: Certain pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds that inhibit cycline dependent kinase (CDK) (e.g., CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDK10, CDK11, CDK12, CDK13, etc.) are disclosed. Pharmaceutical compositions comprising these compounds, and the use of these compounds and compositions to inhibit CDK; to treat disorders associated with CDK such as those arising from an inappropriate activity, mutation, overexpression, or upstream pathway activation of CDK; or disorders that are ameliorated by the inhibition of CDK; proliferative disorders; cancer; viral infections; neurodegenerative disorders; ischaemia; renal diseases; and cardiovascular disorders are also disclosed. Optionally, the treatment further comprises simultaneous or sequential treatment with a further active agent, e.g., an aromatase inhibitor, an anti-estrogen, a Her2 blocker, a cytotoxic chemotherapeutic agent, etc.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: April 3, 2018
    Assignees: Cancer Research Technology Limited, Imperial Innovations Limited, Emory University
    Inventors: Alexander Bondke, Sebastian Kroll, Anthony Barrett, Matthew Fuchter, Brian Slafer, Simak Ali, Charles Coombes, James Patrick Snyder
  • Patent number: 9934569
    Abstract: A computer implemented method for tracking a site in a series of images, the method comprising identifying a site to be tracked; selecting at least three non-collinear locations distributed around the sire in the reference image; selecting, from the reference image, a region of image data around each of the at least three non collinear locations; comparing each selected region with a second image and, based on these comparisons, identifying for each selected region a corresponding location in the second image, determining a single common affine transformation to map the at least three locations from the reference image onto the corresponding locations in the second image.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: April 3, 2018
    Assignee: Imperial Innovations Limited
    Inventors: Menglong Ye, Stamatia Giannarou, Guang-Zhong Yang
  • Patent number: 9932317
    Abstract: This invention relates to quinazoline compounds of Formula (I) which are inhibitors of the histone lysine methyltransferase (HKMTase) EZH2, and to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of EZH2 provides a therapeutic or prophylactic effect.
    Type: Grant
    Filed: March 19, 2013
    Date of Patent: April 3, 2018
    Assignees: Imperial Innovations Limited, Emory University
    Inventors: Robert Brown, Matthew John Fuchter, Nadine Chapman-Rothe, Nitipol Srimongkolpithak, Joachim Caron, James Snyder, Thota Ganesh, Jin Liu, Aiming Sun
  • Patent number: 9902903
    Abstract: The present invention relates to compositions capable of emitting circularly polarized electroluminescence comprising an electroluminescent polymer and a chiral dopant, processes for the synthesis of such compositions and light emitting devices incorporating such compositions.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: February 27, 2018
    Assignee: IMPERIAL INNOVATIONS LIMITED
    Inventors: Matthew Fuchter, Alasdair Campbell, Ying Yang
  • Patent number: 9893653
    Abstract: A device able to generate electrical power through relative rotational motion of first (370, 380) and second (200, 230) principal components around an axis of rotation (220); wherein: the first and second principal components comprise an arrangement of piezoelectric elements (380) and permanent magnets (230, 370) such that the interaction between these magnets and piezoelectric elements, in use, makes it possible to generate electricity; and wherein: the second principal component (200, 230) comprises a center of mass offset from the axis of relative rotation (220) such that the response of the second principal component (200, 230) to either gravitational or inertial forces is a relative rotation of the second principal component (200, 230) in relation to the first principal component (370, 380); the first principal component (370, 380) being fixedly attached to the moving host structure (100).
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: February 13, 2018
    Assignee: Imperial Innovations Limited
    Inventors: Eric Morgan Yeatman, Andrew Sean Holmes, Pit Pillatsch
  • Publication number: 20180015211
    Abstract: A blood filter device having an iron-chelating molecule, a haem-binding molecule and a haemoglobin-binding molecule bound to a support. Use of the device in a vessel containing blood, for example a blood bag or a flow line, removes haemolysis-derived components from the blood.
    Type: Application
    Filed: December 2, 2015
    Publication date: January 18, 2018
    Applicants: IMPERIAL INNOVATIONS LIMITED, UCL BUSINESS PLC
    Inventors: Alan Christopher Spivey, Gregory John Quinlan, Nathan Davies
  • Patent number: 9845770
    Abstract: An asymmetric double-entry turbine is provided with a turbine housing that includes a first volute, a second volute and a turbine receiving bore. The first volute has a first exhaust gas inlet and a first exhaust gas outlet. The second volute has a second exhaust gas inlet and a second exhaust gas outlet. The turbine receiving bore is in fluid communication with the first exhaust gas outlet and the second exhaust gas outlet for conducting a flow of exhaust gas from the first exhaust gas outlet and the second exhaust gas outlet out in an axial direction. The first exhaust gas outlet has an angular opening amount of more than 180 degrees around the turbine receiving bore. The second exhaust gas outlet has an angular opening amount of less than 180 degrees around the turbine receiving bore.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 19, 2017
    Assignee: Imperial Innovations Limited
    Inventors: Ricardo Martinez-Botas, Masakazu Sakai
  • Patent number: 9843064
    Abstract: The present invention provides a regenerative fuel cell comprising an anionic membrane capable of selectively passing anions, wherein the pH of the anolyte and/or catholyte is at least 10. The present invention also relates to a method of operating a regenerative fuel cell comprising an anionic membrane capable of selectively passing anions, wherein the pH of the anolyte and/or catholyte is at least 10.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: December 12, 2017
    Assignee: IMPERIAL INNOVATIONS LIMITED
    Inventors: Nigel Brandon, Anthony Kucernak, Vladimir Yufit
  • Publication number: 20170348440
    Abstract: The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium (III) 2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N?-amido-methyl]-1,4,7,10-tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phospocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.
    Type: Application
    Filed: March 20, 2017
    Publication date: December 7, 2017
    Applicants: Medical Research Council, Imperial Innovations Limited
    Inventors: Nazila KAMALY, Tammy Louise KALBER, Gavin David KENNY, Maya THANOU, Andrew David MILLER, Jimmy BELL
  • Publication number: 20170340684
    Abstract: The invention provides a recombinant targeted bacteriophage for expressing a transgene in a target cell transduced with the bacteriophage. The bacteriophage comprises a first nucleic acid sequence encoding a pill capsid minor coat protein that is configured to display a cell-targeting ligand for enabling delivery of the bacteriophage to a target cell, a second nucleic acid sequence encoding at least one pVIII capsid major coat protein that is configured to display a foreign peptide thereon, and a transgene which encodes a protein which exerts a biological effect on the target cell.
    Type: Application
    Filed: May 12, 2014
    Publication date: November 30, 2017
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Amin Hajitou, Teerapong Yata
  • Publication number: 20170329065
    Abstract: There is provided a light source arranged to output light at a first wavelength. The light source comprises a luminescent concentrator having a slab-shaped geometry. The luminescent concentrator comprises: an input port arranged to receive light and define a first area; an output port arranged to transmit light and define a second area which is smaller than the first area; and surfaces arranged to direct light inside the luminescent concentrator to the output port. The luminescent concentrator further comprises lumophores arranged to receive light at a second wavelength and emit light at the first wavelength; and a pump light supply coupled to the input port and arranged to illuminate the input port with light at the second wavelength.
    Type: Application
    Filed: October 21, 2015
    Publication date: November 16, 2017
    Applicant: Imperial Innovations Limited
    Inventors: Juna Sathian, Mark Oxborrow
  • Publication number: 20170260325
    Abstract: The invention relates to novel conjugated polymers containing one or more units based on dithieno[3,2-c;2?,3?-e]azepine-4,6-dione that is fused to further aromatic rings, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising, or being prepared from, these polymers, polymer blends, mixtures or formulations.
    Type: Application
    Filed: August 12, 2015
    Publication date: September 14, 2017
    Applicants: Merck Patent GmbH, IMPERIAL INNOVATIONS LIMITED
    Inventors: Nicolas BLOUIN, William MITCHELL, Martin HEENEY, Jessica SHAW
  • Patent number: D812750
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: March 13, 2018
    Assignee: Imperial Innovations Limited
    Inventors: Guang-Zhong Yang, Stephen Matthews